Sinn HP - Search Results

1

The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.

Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C, Thuerigen O, Sinn HP, Akhtar A, Lichter P. Pfister S, et al. Among authors: sinn hp. Int J Cancer. 2008 Mar 15;122(6):1207-13. doi: 10.1002/ijc.23283. Int J Cancer. 2008. PMID: 18058815

2

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.

Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H. Dall P, et al. Among authors: sinn hp. Int J Cancer. 1995 Feb 8;60(4):471-7. doi: 10.1002/ijc.2910600408. Int J Cancer. 1995. PMID: 7530237

3

Survival and tumor characteristics of German hereditary breast cancer patients.

Hamann U, Sinn HP. Hamann U, et al. Among authors: sinn hp. Breast Cancer Res Treat. 2000 Jan;59(2):185-92. doi: 10.1023/a:1006350518190. Breast Cancer Res Treat. 2000. PMID: 10817354

4

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

Schilling T, Bürck J, Sinn HP, Clemens A, Otto HF, Höppner W, Herfarth C, Ziegler R, Schwab M, Raue F. Schilling T, et al. Among authors: sinn hp. Int J Cancer. 2001 Jan 20;95(1):62-6. doi: 10.1002/1097-0215(20010120)95:1<62::aid-ijc1011>3.0.co;2-1. Int J Cancer. 2001. PMID: 11241313

5

Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.

Seute A, Sinn HP, Schlenk RF, Emig R, Wallwiener D, Grischke EM, Hohaus S, Döhner H, Haas R, Bentz M. Seute A, et al. Among authors: sinn hp. Int J Cancer. 2001 Jul 1;93(1):80-4. doi: 10.1002/ijc.1296. Int J Cancer. 2001. PMID: 11391625

6

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

7

C-myc oncogene amplification in ductal carcinoma in situ of the breast.

Aulmann S, Bentz M, Sinn HP. Aulmann S, et al. Among authors: sinn hp. Breast Cancer Res Treat. 2002 Jul;74(1):25-31. doi: 10.1023/a:1016061327812. Breast Cancer Res Treat. 2002. PMID: 12150449

8

Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.

Beckhove P, Schütz F, Diel IJ, Solomayer EF, Bastert G, Foerster J, Feuerer M, Bai L, Sinn HP, Umansky V, Schirrmacher V. Beckhove P, et al. Among authors: sinn hp. Int J Cancer. 2003 Jul 1;105(4):444-53. doi: 10.1002/ijc.11125. Int J Cancer. 2003. PMID: 12712433

9

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.

Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, Ho AD, Bastert G, Krämer A. Schneeweiss A, et al. Among authors: sinn hp. Int J Cancer. 2003 Nov 10;107(3):346-52. doi: 10.1002/ijc.11408. Int J Cancer. 2003. PMID: 14506732

10

Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.

Weber-Mangal S, Sinn HP, Popp S, Klaes R, Emig R, Bentz M, Mansmann U, Bastert G, Bartram CR, Jauch A. Weber-Mangal S, et al. Among authors: sinn hp. Int J Cancer. 2003 Nov 20;107(4):583-92. doi: 10.1002/ijc.11460. Int J Cancer. 2003. PMID: 14520696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters